Veggie Rx: A pilot, 3-arm randomized controlled trial of a fruit and vegetable prescription program for patients with type two diabetes
Veggie Rx:针对二型糖尿病患者的水果和蔬菜处方计划的试点、三组随机对照试验
基本信息
- 批准号:10735542
- 负责人:
- 金额:$ 33.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultCaloriesCaringCarotenoidsClinicClinicalClinical TrialsCommunitiesConsumptionControl GroupsDataDiabetes MellitusDietDietary intakeDiseaseEducationEnrollmentEthnic OriginEvaluationFacultyFatty acid glycerol estersFoodFutureGlycosylated hemoglobin AHealthy EatingHispanicHourHouseholdIncentivesIntakeInterventionKnowledgeLow Income PopulationLow incomeMeasuresMedicaidMedicalMethodologyMindMissionNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusNot Hispanic or LatinoNutrientOutcomeParticipantPathway interactionsPatientsPharmaceutical PreparationsPlasmaProcessProctor frameworkProgram AppropriatenessRaceRandomized, Controlled TrialsRecommendationResearchSurveysTaxonomyTestingWorkagedarmblood glucose regulationcare providersclinical carecostdesigndiabetes self-managementdietary guidelinesfood insecurityfood securityfruits and vegetablesglycemic controlgroup interventionhigh riskhispanic communityimplementation outcomesimplementation scienceimprovedindexinginnovationnutritionprimary care clinicprogramsresponsesexsociodemographic factorssociodemographicssugartreatment as usualtreatment planningtrial designuptakeusual care armvoucher
项目摘要
Abstract. Consuming a nutrient-dense diet, rich in fruits and vegetables (F&Vs) is at the cornerstone of type 2
diabetes (T2DM) treatment. Yet, among Hispanic adults, only 16% meet the recommended minimum F&V
intake recommendations and they have higher rates of T2DM than non-Hispanic whites (16.6% versus 13.3%,
respectively). F&V Prescription (F&V Rx) programs are embedded in clinical settings, target medically high-risk
patients such as those with T2DM, and provide them with vouchers to purchase F&V at local retailers.
Preliminary F&V Rx studies in patients with T2DM have found F&V intake increases of 0.2-1.6 servings per
day and hemoglobin A1c (A1c) reductions from 0.35-0.71% [3.8 -7.8 mmol/mol]. However, none of these
studies included diabetes self-management education and support (DSME/S) which can lead to A1c decreases
from 0.24% to 1.0% [2.6-10.9 mmol/mol]. Our team conducted a pilot F&V Rx study where we incentivized
DSME/S attendance by providing a F&V Rx at each session. Although DSME/S uptake is typically very low
after referral (around 5-7%), our program had a 73% first session attendance rate. Further, at 7 months post-
program, we found a clinically- and statistically-significant reduction in A1c of 1.3% [14.2 mmol/mol] (p=.001).
Although the receipt of the F&V Rx vouchers was contingent upon DSME/S attendance in our study, other
T2DM-focused F&V Rx studies did not have DSME/S attendance requirements and they also saw A1c
reductions. Thus, understanding the effect of a F&V Rx on DSME/S uptake and retention with and without
attendance requirements is a key design issue that must be evaluated. This proposal is in response to PAS 20-
160 for short-term, pilot randomized controlled trials (RCTs) to acquire preliminary data regarding trial design.
We propose a 3-Arm, 16-week, pilot RCT (n=120) for low-income adults (aged 18+) with T2DM (A1c >7% [53
mmol/mol]). The control group (n=40) will receive usual care (UC). The two intervention groups (n=40 each)
will receive UC plus a F&V Rx that is either independent of DSME/S attendance (F&V Rx alone) or dependent
on DSME/S attendance (F&V Rx + DSME/S). First, we will systematically explore the impact of a F&V Rx on
uptake and retention in DSME/S. Next, we will explore changes in A1c, and diet-related outcomes. Finally, with
implementation in mind, we will use Proctor’s implementation taxonomy, and the cultural adaptation framework
from Castro et al., to assess program appropriateness, acceptability, and sustainability with both participants
and clinical care providers. Our study team and our Community Advisory Board (CAB) have the research,
clinical expertise, and established retail network necessary to conduct a F&V Rx trial in a low-income, Hispanic
community. The findings of this trial will inform the design of a future, fully powered RCT and address gaps in
our knowledge related to how F&V Rx programs impact T2DM-related outcomes. If effective, F&V Rx
programs have the potential to improve diabetes self-management and reduce the clinical burden of poor
glycemic control, particularly in low-income, Hispanic communities.
抽象的。吃营养密集的饮食,富含水果和蔬菜(F&V)是2型糖尿病的基石
糖尿病(T2 DM)治疗。然而,在西班牙裔成年人中,只有16%达到了推荐的最低F&V标准
他们的T2 DM患病率高于非西班牙裔白人(16.6%比13.3%,
)。F&V处方(F&V Rx)计划嵌入临床环境,针对医疗高危人群
例如T2 DM患者,并向他们提供在当地零售商购买F&V的代金券。
对T2 DM患者进行的初步F&V Rx研究发现,每餐F&V摄入量增加0.2-1.6份
天数和糖化血红蛋白(A1c)从0.35-0.71%[3.8-7.8 mmol/mol]降低。然而,这些都不是
研究包括糖尿病自我管理教育和支持(DSME/S),这可能导致A1c下降
0.24%~1.0%[2.6~10.9 mmol/mol]。我们的团队进行了一项F&V Rx试点研究,在该研究中,我们激励
DSME/S出席,在每次会议上提供F&V Rx。尽管DSME/S的接受率通常很低
转介后(约5%-7%),我们的项目首期出席率为73%。此外,在7个月后-
计划中,我们发现A1c在临床和统计学上显著降低了1.3%[14.2 mmol/mol](p=.001)。
虽然F&V Rx代金券的收到取决于DSME/S是否参加我们的研究,但其他
专注于T2 DM的F&V Rx研究没有DSME/S的出勤要求,他们也看到了A1C
减税。因此,了解F&V Rx对DSME/S摄取和留存的影响
出勤要求是必须评估的关键设计问题。此建议是对PAS 20的回应-
160用于短期、先导性随机对照试验(RCT),以获得有关试验设计的初步数据。
我们建议为患有T2 DM(A1c&>7%)的低收入成年人(18岁以上)进行为期16周的3臂试验性随机对照试验(n=120)。
摩尔/摩尔])。对照组(n=40)接受常规护理(UC)。两个干预组(n=40)
将获得UC加F&V Rx,该F&V Rx独立于DSME/S出席(仅F&V Rx)或取决于
DSME/S出席(F&V Rx+DSME/S)。首先,我们将系统地探索F&V Rx对
DSME/S的摄取和滞留。接下来,我们将探索A1c的变化,以及与饮食相关的结果。最后,有了
考虑到实施,我们将使用Proctor的实施分类法和文化适应框架
来自Castro等人,与两个参与者一起评估计划的适当性、可接受性和可持续性
和临床护理提供者。我们的研究团队和我们的社区咨询委员会(CAB)进行了这项研究,
临床专业知识,以及在低收入西班牙裔美国人中进行F&V Rx试验所需的成熟零售网络
社区。这项试验的结果将为未来全功率随机对照试验的设计提供参考,并填补
我们的知识与F&V Rx计划如何影响T2 DM相关结果相关。如果有效,F&V Rx
这些计划有可能改善糖尿病的自我管理,减轻穷人的临床负担
血糖控制,特别是在低收入的西班牙裔社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Veldheer其他文献
Susan Veldheer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 33.46万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 33.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




